Epigene Labs announces multi-year expansion of collaboration with Servier
This partnership aims to accelerate and increase precision of Servier’s oncology clinical trials enabled by Epigene’s mCUBE platform.
Le Point magazine unveils its 2025 inventors’ rankings – the 100 inventions that will change our lives (French read)
Behind every invention lies an innovative vision, a bet on human intelligence, and a promise: to reconcile progress with hope.
Sifted, backed by FT, includes Epigene Labs in its 2024 investment-grade research on drug discovery
Find the European drug discovery market map with the 64 startups selected by Sifted, from pre-seed to Series A.
Epigene Labs: a future champion of precision oncology?
Discover how our cutting-edge approach and groundbreaking advances are shaping the future of precision oncology in Biotech Finances.
The EIC fund materializes its support to Epigene Labs to accelerate precision oncology R&D
This investment heralds outstanding
technological and scientific strides made by Epigene Labs, which also received a multimillion grant last year as part of the EIC Accelerator program.
STATION F unveils TOP30 2020, its group featuring the most advanced startups of the campus
STATION F reveals its TOP30 2020, highlighting the most advanced startups on campus. Discover the innovators who raised over €60M.
Epigene Labs raises 1.4 million euros
Learn how Epigene Labs raised €1.4M to accelerate AI-driven genomic data analysis, revolutionizing oncology drug discovery.
TICPharma, leading French-speaking healthcare and pharma news website, features Epigene Labs
Featured in TICPharma, discover how our platform identifies biomarkers new cancer drug targets.
Startups: why young scientists are taking the leap
Aiming for immediate impact, PhD students and postdoctoral researchers worldwide are drawn to entrepreneurship.
Artificial intelligence startups supporting oncology (French read)
With 382,000 new cancer cases in France in 2018, this 21st-century scourge also creates opportunities for startups.
